{"database": "lobbying", "table": "lobbying_activities", "rows": [[1988605, "99468de0-9ddd-425a-8e5f-b31e3ce595e6", "Q2", "THE SMITH-FREE GROUP, LLC", 35800, "UNIVERSAL CORPORATION", 2017, "second_quarter", "TOB", "Discussions involving FDA regulation of Nitrosonoronicotine\n\nH.R. 1136 FDA Deeming Authority Clarification Act of 2017(All sections of full text)", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-07-17T10:21:02.933000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1988605"], "units": {}, "query_ms": 57.371598086319864, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}